Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy.
Rockey
D C
DC
D000804:Angiotensin II / Q000009:adverse effects*; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy* / Q000473:pathology*; D008102:Liver Circulation / Q000187:drug effects; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000473:pathology*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D014662:Vasoconstrictor Agents; D000804:Angiotensin II